Select Medical Holdings Co. (NYSE:SEM) Shares Purchased by JPMorgan Chase & Co.

JPMorgan Chase & Co. boosted its position in Select Medical Holdings Co. (NYSE:SEM) by 9.7% in the third quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 416,299 shares of the health services provider’s stock after purchasing an additional 36,905 shares during the period. JPMorgan Chase & Co. owned about 0.32% of Select Medical worth $14,516,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other hedge funds have also recently added to or reduced their stakes in SEM. Point72 Asset Management L.P. lifted its position in Select Medical by 144.2% in the third quarter. Point72 Asset Management L.P. now owns 2,059,791 shares of the health services provider’s stock valued at $71,825,000 after purchasing an additional 1,216,263 shares during the period. Millennium Management LLC lifted its position in shares of Select Medical by 183.9% during the 2nd quarter. Millennium Management LLC now owns 679,522 shares of the health services provider’s stock valued at $23,824,000 after acquiring an additional 440,140 shares during the period. Hood River Capital Management LLC acquired a new stake in shares of Select Medical during the 2nd quarter valued at approximately $14,819,000. Loomis Sayles & Co. L P acquired a new stake in shares of Select Medical during the 3rd quarter valued at approximately $9,710,000. Finally, LMR Partners LLP acquired a new stake in shares of Select Medical during the 3rd quarter valued at approximately $6,139,000. Institutional investors and hedge funds own 89.48% of the company’s stock.

Analyst Ratings Changes

A number of research firms have recently issued reports on SEM. Royal Bank of Canada lifted their price target on shares of Select Medical from $40.00 to $47.00 and gave the company an “outperform” rating in a research report on Monday, November 4th. Benchmark downgraded shares of Select Medical from a “buy” rating to a “hold” rating in a research report on Monday, November 25th. UBS Group reduced their price target on shares of Select Medical from $40.00 to $21.00 and set a “neutral” rating for the company in a research report on Friday, January 3rd. Finally, StockNews.com upgraded shares of Select Medical from a “hold” rating to a “buy” rating in a research report on Tuesday. Two investment analysts have rated the stock with a hold rating and three have given a buy rating to the company. According to MarketBeat.com, Select Medical currently has an average rating of “Moderate Buy” and an average price target of $39.50.

Insiders Place Their Bets

In other Select Medical news, VP Robert G. Breighner, Jr. sold 4,989 shares of Select Medical stock in a transaction that occurred on Wednesday, December 4th. The shares were sold at an average price of $19.95, for a total value of $99,530.55. Following the completion of the sale, the vice president now directly owns 30,356 shares of the company’s stock, valued at approximately $605,602.20. The trade was a 14.12 % decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, Director Marilyn B. Tavenner sold 32,000 shares of Select Medical stock in a transaction that occurred on Tuesday, November 26th. The stock was sold at an average price of $21.09, for a total transaction of $674,880.00. Following the completion of the sale, the director now directly owns 22,000 shares of the company’s stock, valued at $463,980. The trade was a 59.26 % decrease in their ownership of the stock. The disclosure for this sale can be found here. 19.14% of the stock is owned by corporate insiders.

Select Medical Trading Down 2.2 %

Shares of SEM opened at $18.32 on Friday. The company has a debt-to-equity ratio of 1.37, a current ratio of 1.13 and a quick ratio of 1.13. The firm has a 50 day simple moving average of $25.44 and a 200-day simple moving average of $31.67. Select Medical Holdings Co. has a 1-year low of $18.02 and a 1-year high of $40.98. The stock has a market cap of $2.37 billion, a price-to-earnings ratio of 8.56, a price-to-earnings-growth ratio of 0.39 and a beta of 1.45.

Select Medical (NYSE:SEM) last issued its quarterly earnings data on Thursday, October 31st. The health services provider reported $0.43 earnings per share for the quarter, topping analysts’ consensus estimates of $0.36 by $0.07. Select Medical had a net margin of 3.97% and a return on equity of 15.99%. The business had revenue of $1.76 billion during the quarter, compared to analysts’ expectations of $1.74 billion. During the same period last year, the company posted $0.46 EPS. The company’s revenue was up 5.7% on a year-over-year basis. Equities analysts forecast that Select Medical Holdings Co. will post 1.97 EPS for the current fiscal year.

Select Medical Announces Dividend

The company also recently announced a quarterly dividend, which was paid on Tuesday, November 26th. Shareholders of record on Wednesday, November 13th were paid a $0.125 dividend. The ex-dividend date of this dividend was Wednesday, November 13th. This represents a $0.50 annualized dividend and a yield of 2.73%. Select Medical’s payout ratio is currently 23.36%.

About Select Medical

Select Medical Holdings Corporation, through its subsidiaries, operates critical illness recovery hospitals, rehabilitation hospitals, outpatient rehabilitation clinics, and occupational health centers in the United States. It operates in four segments: Critical Illness Recovery Hospital, Rehabilitation Hospital, Outpatient Rehabilitation, and Concentra.